HomeNewsIndiaHere are five things to know about the new EPF rules

Here are five things to know about the new EPF rules

This move will also introduce liquidity of Rs 6,750 crores to employers and employees over the course of three months.

May 19, 2020 / 19:40 IST
Story continues below Advertisement

The labour ministry has notified the new rules for employees’ provident fund or EPF contribution.

In an announcement last week, Finance Minister Nirmala Sitharama stated that the statutory provident fund contribution by the employers as well as employees will see a reduction from 12% to 10% for the next three months.

Story continues below Advertisement

This decision directly impacts the in-hand salary of the employees and also gives relief to companies in payment of provident fund dues.

This move will also introduce liquidity of ₹6,750 crores to employers and employees over the course of next three months.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show